Alcohol consumption patterns amongst hepatitis C positive people receiving opioid maintenance treatment

2005 ◽  
Vol 38 (05) ◽  
Author(s):  
FM Wurst ◽  
B Watson ◽  
PS Haber ◽  
J Whitfield ◽  
C Wallace ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Alcohol Consumption ◽  
Maintenance Treatment ◽  
Consumption Patterns ◽  
Opioid Maintenance Treatment

ALCOHOL CONSUMPTION PATTERNS AMONGST HEPATITIS C POSITIVE PEOPLE RECEIVING OPIOID MAINTENANCE TREATMENT.

2004 ◽  
Vol 28 (Supplement) ◽  
pp. 52A
Author(s):  
B Watson ◽  
P S. Haber ◽  
K M. Conigrave ◽  
J B. Whitfield ◽  
C Wallace ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Alcohol Consumption ◽  
Maintenance Treatment ◽  
Consumption Patterns ◽  
Opioid Maintenance Treatment

scholarly journals Benzodiazepine Use in Opioid Maintenance Treatment Programme: Risks and Clinical Outcomes

2021 ◽  
Vol 34 (3) ◽  
pp. 209
Author(s):  
Catarina Oliveira ◽  
Rita Filipe ◽  
João Meira ◽  
Lara Sampaio ◽  
Leonor Teixeira ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Clinical Outcomes ◽  
Maintenance Treatment ◽  
Treatment Effectiveness ◽  
Multivariable Analysis ◽  
High Rate ◽  
Opioid Maintenance Treatment ◽  
Cross Sectional ◽  
Increased Risk ◽  
Benzodiazepine Use

Introduction: The co-association of benzodiazepines and opioids is associated with an increased risk of overdose, death, and poorer psychosocial prognosis. The aim of this study is to characterize the prevalence, pattern of use, and primary clinical outcomes in benzodiazepines users in a public opioid maintenance treatment unit.Material and Methods: We conducted a cross-sectional study involving 236 patients treated with opioid substitutes (methadone and buprenorphine). We conducted a descriptive, bivariable, and multivariable analysis to determine clinical differences between benzodiazepines users and non-users.Results: The prevalence of consumption of benzodiazepines was 25.4% (60). The benzodiazepines were obtained with a medical prescription (49.8%) or on the black market (42.6%). The most prescribed benzodiazepine was diazepam (29.1%), and the main reasons were to relieve insomnia (27.7%) or anxiety (26.9%) and to enhance the psychoactive effects of other drugs (19.7%). Regarding the clinical outcomes, we highlight: a very high prevalence of hepatitis C (51.7%); severe ongoing consumption of psychoactive drugs (73.7%); and a high rate of depression and anxiety (> 60%), significantly higher in the benzodiazepines-user group. In the multivariable analysis of benzodiazepine use, we found alcohol consumption (OR 0.482; IC 95% 0.247, 0.238) had a negative association and having hepatitis C (OR 2.544, IC 95% 1.273, 5.084) or anxiety symptoms (OR 5.591; IC 95% 2.345, 13.326) had positive associations.Discussion: Our results suggest the BZD users had a complex drug addiction problem and underline the importance of adequately addressing BZD use, contemplating psychological and psychiatric approach in this particular population.Conclusion: Past or current use of benzodiazepines is associated with poor clinical and psychiatric outcomes. A multidisciplinary approach with a focus on infectious diseases and mental health is critical in order to enhance the treatment effectiveness and overall prognosis.

Alcohol consumption patterns in heavy drinkers with and without alcoholic liver disease (ALD)

2001 ◽  
Vol 120 (5) ◽  
pp. A117-A117
Author(s):  
K DEAR ◽  
M BRADLEY ◽  
K MCCORMACK ◽  
R PECK ◽  
D GLEESON
Keyword(s):  
Liver Disease ◽  
Alcohol Consumption ◽  
Alcoholic Liver Disease ◽  
Consumption Patterns ◽  
Heavy Drinkers

scholarly journals The “black box” of treatment: Patients’ perspective on what works in opioid maintenance treatment for opioid dependence

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Teresa C. Silva ◽  
Fredrik B. Andersson
Keyword(s):  
Opioid Dependence ◽  
Maintenance Treatment ◽  
Treatment Plan ◽  
Black Box ◽  
Opioid Maintenance Treatment ◽  
Convenience Sample ◽  
Problematic Use ◽  
Treatment Stage ◽  
Pre Treatment ◽  
Patients Perspective

Abstract Background A lack of conceptual modeling of how the components of opioid maintenance treatment (OMT) for opioid dependence (OD) work causes it to occasionally be labeled the “black-box” of treatment. This study had a two-fold objective: First, to analyze which factors related to OMT for OD contribute to the abstinence of problematic use of non-prescribed opioids and sustain recovery, from the patients’ perspective; second, to understand which changes OMT produced in the individuals’ lives might significantly contribute to relapse prevention. Methods We used qualitative methods of design, inquiry, and analysis from a convenience sample of 19 individuals in a Swedish treatment setting. Results All the participants reported previous cycles of problematic use of non-prescribed opioids and other non-prescribed psychoactive substances, treatment, abstinence, recovery, and relapse before starting the current OMT program. During the pre-treatment stage, specific events, internal processes, and social environments enhanced motivation toward abstinence and seeking treatment. During the treatment stage, participants perceived the quality of the human relationships established with primary social groups as important as medication and the individual plan of care in sustaining recovery. From the participants’ perspective, OMT was a turning point in their life course, allowing them a sense of self-fulfillment and the reconstruction of personal and social identity. However, they still struggled with the stigmatization produced by a society that values abstinence-oriented over medication-assisted treatments. Conclusion OMT is not an isolated event in individuals’ lives but rather a process occurring within a specific social context. Structural factors and the sense of acceptance and belonging are essential in supporting the transformation. Treatment achievements and the risk for relapse vary over time, so the objectives of the treatment plan must account for characteristics of the pre-treatment stage and the availability and capacity of individuals to restructure their social network, besides the opioid maintenance treatment and institutional social care.

Delivering opioid maintenance treatment in rural and remote settings

2015 ◽  
Vol 23 (4) ◽  
pp. 201-206 ◽  
Author(s):  
Lynda Berends ◽  
Andrew Larner ◽  
Dan I. Lubman
Keyword(s):  
Maintenance Treatment ◽  
Rural And Remote ◽  
Opioid Maintenance Treatment
Sign in / Sign up

Export Citation Format

Share Document